LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

German Association of Biotechnology Industries: Biotech regulation: Making Europe fit for the future

07/02/2025

POLICY DOCUMENT

Germany, February 2025 - BioTech Brief: Making Europe fit for the future. 

This BioTech Letter focuses on biotechnology regulation and was published by the German Association of Biotechnology Industries within the German Chemical Industry Association - VCI. 

"In early September 2024, Mario Draghi, the EU‘s special representative for competitiveness, presented a dramatic analysis. The key message: Europe urgently needs more innovation and investment in future-oriented economic sectors. The continent must overcome its static industrial structure and massively increase its productivity. The EU initiative „Boosting Biotechnology and Biomanufacturing“ is a unique opportunity for the EU and its Member States to take urgent and
immediate action to support and expand biotechnology and biotech manufacturing in the EU."

Source: Deutsche Industrievereinigung Biotechnologie (DIB).

German Association of Biotechnology Industries: Biotech regulation: Making Europe fit for the future


Download

Share
Communications Team
Communications Team

Related posts

14/07/2025

EuropaBio Annual Report 2025


Read more
26/06/2025

Health Biomanufacturing: Feedstock for Preparedness and Resilience


Read more
30/05/2025

Open Letter of Business and Agri-Food Industry stakeholders on the need for a high-performing EFSA to boost the competitiveness of the EU agri-food sector


Read more

Important links

  • Public Consultation Response to the European Commission’s 28th Regime proposal
  • EuropaBio Annual Report 2025

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.